Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by besttobeon Aug 03, 2021 8:41am
140 Views
Post# 33641466

RE:RE:RE:RE:RE:RE:SEC 10Q reports Phillips recall and OIG ( in limbo )

RE:RE:RE:RE:RE:RE:SEC 10Q reports Phillips recall and OIG ( in limbo )Longterm...What I just posted were reports just filed by MGT to the SEC and relevant, as it is the first update provided by the company in awhile. I was thinking a buying again, if reports and guidance was more favorable. In the past I posted articles relevant to the stock as well. Sorry you don't appreciate a realistic view. 

Lamburt...growth slowed prior to covid and the stock went to $8.00. During covid the revenue and income climbed and so did the S/P to $16.00. Now that covid is not a factor for them, they have once again, returned to low organic growth. Thus the S/P back to $8.00, plus the other issues. 
<< Previous
Bullboard Posts
Next >>